Isabel Chu

2.3k total citations · 1 hit paper
12 papers, 1.8k citations indexed

About

Isabel Chu is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Isabel Chu has authored 12 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Isabel Chu's work include Cancer-related Molecular Pathways (3 papers), RNA modifications and cancer (2 papers) and Estrogen and related hormone effects (2 papers). Isabel Chu is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), RNA modifications and cancer (2 papers) and Estrogen and related hormone effects (2 papers). Isabel Chu collaborates with scholars based in United States, Canada and Austria. Isabel Chu's co-authors include Joyce M. Slingerland, Ludger Hengst, Susie Chen, Kimberly Blackwell, Jun Sun, Angel Arnaout, Jeffrey E. Green, Lara H. El Touny, Aleksandra M. Michalowski and Cheng‐Keat Tan and has published in prestigious journals such as Cell, Journal of Clinical Investigation and Nature reviews. Cancer.

In The Last Decade

Isabel Chu

12 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy

2008 797 citations Isabel Chu, Ludger Hengst et al. Nature reviews. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Isabel Chu United States	11	1.1k	1.0k	346	267	213	12	1.8k
Agnieszka Zagożdżon United States	12	1.3k 1.2×	889 0.9×	248 0.7×	348 1.3×	317 1.5×	21	1.9k
Yoshimi Arima Japan	27	1.2k 1.0×	906 0.9×	396 1.1×	297 1.1×	291 1.4×	46	2.0k
Elisabeth E. Bond United States	9	1.5k 1.3×	1.3k 1.3×	487 1.4×	145 0.5×	152 0.7×	15	2.1k
Leslie A. Parsels United States	24	1.5k 1.3×	1.4k 1.4×	349 1.0×	255 1.0×	289 1.4×	39	2.1k
Ricardo Sánchez‐Prieto Spain	26	1.3k 1.2×	696 0.7×	374 1.1×	144 0.5×	272 1.3×	74	2.1k
Jeremy P. Blaydes United Kingdom	32	1.6k 1.4×	987 1.0×	342 1.0×	133 0.5×	119 0.6×	54	2.2k
Rozita Bagheri‐Yarmand United States	23	1.5k 1.3×	780 0.8×	292 0.8×	394 1.5×	159 0.7×	45	2.0k
Matthias Drosten Spain	22	1.4k 1.3×	777 0.8×	291 0.8×	254 1.0×	261 1.2×	43	2.0k
Teresa Klinowska United Kingdom	22	1.3k 1.1×	717 0.7×	252 0.7×	150 0.6×	419 2.0×	62	2.0k
Alberto Martín Spain	12	1.2k 1.1×	840 0.8×	222 0.6×	403 1.5×	323 1.5×	23	1.7k

Countries citing papers authored by Isabel Chu

Since Specialization

Citations

This map shows the geographic impact of Isabel Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Chu more than expected).

Fields of papers citing papers by Isabel Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Chu. The network helps show where Isabel Chu may publish in the future.

Co-authorship network of co-authors of Isabel Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Chu. A scholar is included among the top collaborators of Isabel Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Chu. Isabel Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Tsai, C. Y., et al.. (2021). Synthetic dysmobility screen unveils an integrated STK40-YAP-MAPK system driving cell migration. Science Advances. 7(31). 3 indexed citations

Lohmueller, Jason, Shuji Sato, Lana Popova, et al.. (2016). Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potential. Scientific Reports. 6(1). 32 indexed citations

Chu, Isabel, W. Victoria Lai, Olga Aprelikova, et al.. (2013). Expression of GATA3 in MDA-MB-231 Triple-negative Breast Cancer Cells Induces a Growth Inhibitory Response to TGFß. PLoS ONE. 8(4). e61125–e61125. 25 indexed citations

Bennett, Christina N., Christine C. Tomlinson, Aleksandra M. Michalowski, et al.. (2012). Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer. Breast Cancer Research. 14(4). R109–R109. 26 indexed citations

Barkan, Dalit, Lara H. El Touny, Aleksandra M. Michalowski, et al.. (2010). Metastatic Growth from Dormant Cells Induced by a Col-I–Enriched Fibrotic Environment. Cancer Research. 70(14). 5706–5716. 308 indexed citations

Das, Sudipto, Allen D. Bosley, Xiaoying Ye, et al.. (2010). Comparison of Strong Cation Exchange and SDS-PAGE Fractionation for Analysis of Multiprotein Complexes. Journal of Proteome Research. 9(12). 6696–6704. 19 indexed citations

Hoenerhoff, Mark J., Isabel Chu, Daniel Barkan, et al.. (2009). BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases. Oncogene. 28(34). 3022–3032. 86 indexed citations

Chu, Isabel, Ludger Hengst, & Joyce M. Slingerland. (2008). The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nature reviews. Cancer. 8(4). 253–267. 797 indexed citations breakdown →

Chu, Isabel, Angel Arnaout, Jun Sun, et al.. (2007). Src promotes estrogen-dependent estrogen receptor α proteolysis in human breast cancer. Journal of Clinical Investigation. 117(8). 2205–2215. 72 indexed citations

10.

Chu, Isabel, Jun Sun, Angel Arnaout, et al.. (2007). p27 Phosphorylation by Src Regulates Inhibition of Cyclin E-Cdk2. Cell. 128(2). 281–294. 292 indexed citations

11.

Chu, Isabel, Kimberly Blackwell, Susie Chen, & Joyce M. Slingerland. (2005). The Dual ErbB1/ErbB2 Inhibitor, Lapatinib (GW572016), Cooperates with Tamoxifen to Inhibit Both Cell Proliferation- and Estrogen-Dependent Gene Expression in Antiestrogen-Resistant Breast Cancer. Cancer Research. 65(1). 18–25. 161 indexed citations

12.

Szmitko, Paul E., Anthony Brade, Isabel Chu, et al.. (2003). Kinase-dead PKB gene therapy combined with hyperthermia for human breast cancer. Cancer Gene Therapy. 11(1). 52–60. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact